Katy Barglow is a Biochemist with over a decade of experience in biologics process development, production, and analytical characterization. She graduated from Stanford University with a B.S. degree in Chemistry and from the Scripps Research Institute with a Ph.D. in Chemical Biology, and was a Postdoctoral Fellow of the American Cancer Society at UC Berkeley.
Her biologics development experience spans pre-clinical and clinical PD to commercial manufacturing support on both the Process and Analytical/QC side. At Baxter (now Shire), Dr. Barglow rapidly climbed the Scientist ranks within Process Development and supported both IND and BLA filings. At Grifols Diagnostics (formerly Novartis), she handled process deviations for commercial recombinant proteins as a Sr. Process Expert, and was the Group Leader for the Analytical Development group. She has extensive experience in advanced characterization of biologics, process monitoring and control, and tech transfer for both assays and processes.